Vimarsana
Biggest News Aggregation in the World

Page 5 - Director Beth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Beth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Beth Today - Breaking & Trending Today

Vivo Capital LLC Trims Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Vimarsana News

Vivo Capital LLC Trims Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA)

Vivo Capital LLC lessened its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Rating) by 39.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 400,666 shares of the company’s stock after selling 266,000 shares during the quarter. Vera Therapeutics comprises approximately […]

Piper Sandler Initiates Coverage on Acelyrin (NASDAQ:SLRN) - Vimarsana News

Piper Sandler Initiates Coverage on Acelyrin (NASDAQ:SLRN)

Piper Sandler started coverage on shares of Acelyrin (NASDAQ:SLRN – Get Rating) in a research note released on Tuesday morning, The Fly reports. The brokerage issued an overweight rating and a $68.00 target price on the stock. Acelyrin Price Performance Shares of SLRN stock opened at $17.50 on Tuesday. Acelyrin has a 12 month low […]

TD Cowen Begins Coverage on Acelyrin (NASDAQ:SLRN) - Vimarsana News

TD Cowen Begins Coverage on Acelyrin (NASDAQ:SLRN)

TD Cowen initiated coverage on shares of Acelyrin (NASDAQ:SLRN – Get Rating) in a report issued on Tuesday, Briefing.com reports. The firm issued an outperform rating on the stock. A number of other equities research analysts have also recently commented on SLRN. Jefferies Financial Group assumed coverage on shares of Acelyrin in a research report […]

Source: wkrb13.com
Acelyrin (NASDAQ:SLRN) Earns Overweight Rating from Analysts at Piper Sandler - Vimarsana News

Acelyrin (NASDAQ:SLRN) Earns Overweight Rating from Analysts at Piper Sandler

Piper Sandler initiated coverage on shares of Acelyrin (NASDAQ:SLRN – Get Rating) in a research note issued to investors on Tuesday morning, The Fly reports. The firm issued an overweight rating and a $68.00 target price on the stock. Acelyrin Price Performance Shares of SLRN opened at $17.85 on Tuesday. Acelyrin has a 1-year low […]

Acelyrin (NASDAQ:SLRN) Coverage Initiated at Jefferies Financial Group - Vimarsana News

Acelyrin (NASDAQ:SLRN) Coverage Initiated at Jefferies Financial Group

Investment analysts at Jefferies Financial Group began coverage on shares of Acelyrin (NASDAQ:SLRN – Get Rating) in a research report issued on Tuesday, The Fly reports. The brokerage set a “buy” rating and a $31.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 71.27% from the stock’s […]